Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
185 GBX | +4.23% | -3.90% | -39.34% |
May. 22 | Transcript : Faron Pharmaceuticals Oy - Special Call | |
May. 20 | Faron Pharmaceuticals’ Blood Cancer Combo Shows Efficacy in Mid-stage Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.34% | 169M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Faron Halts Investigational COVID-19 Therapy Trial Due to Low Infection, Hospitalization Rates